JCVPyV |
JCV LT-Ag |
1–36 |
Inhibition of JCV transcription and replication |
Safak et al. (2001) |
JCVPyV |
JCV Sm t-Ag |
ND |
Inhibition of PP2A-mediated dephosphorylation of agnoprotein |
Sariyer et al. (2008) |
JCVPyV |
JCV VP1 |
ND |
Involved in virion assembly |
Suzuki et al. (2012) |
JCVPyV |
HIV-1 Tat |
18–54 |
Inhibition of Tat-mediated HIV promoter activation |
Kaniowska et al. (2006) |
JCVPyV |
p53 |
1–36 |
Suppression of cell cycle progression |
Darbinyan et al. (2002) |
JCVPyV |
Ku70 |
1–36 |
Inhibition of double-strand break repair |
Darbinyan et al. (2004) |
JCVPyV |
PP2A |
18–36 |
Dephosphorylation of agnoprotein |
Sariyer et al. (2008) |
JCVPyV |
YB-1 |
1–36) |
Inhibition of YB-1-mediated transcription of JCV promoters |
Safak et al. (2002) |
JCVPyV |
FEZ1 |
ND |
Inhibition of FEZ1-mediated neurite outgrowth |
Suzuki et al. (2005) |
JCVPyV |
HP1α |
1–18 |
Facilitation of nuclear export of JCV virions |
Okada et al. (2005) |
JCVPyV |
AP-3 |
ND |
Inhibition of PB-3-mediated vesicular trafficking |
Suzuki et al. (2013) |
BKPyV |
α-SNAP |
1–15 |
Inhibition of vesicle transport |
Johannessen et al. (2011) |
BKPyV |
PCNA |
1–15 |
Inhibition of DNA replication |
Gerits et al. (2015) |